Myeloid NF-?B signaling fosters KRAS-mutant tumors

Magda Spella (Patras, Greece)

Source: ERS Lung Science Conference 2017
Number: 12

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Magda Spella (Patras, Greece). Myeloid NF-?B signaling fosters KRAS-mutant tumors. ERS Lung Science Conference 2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Myeloid derived suppressor cells in the crosstalk between COPD and lung cancer
Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Year: 2011

Late Breaking Abstract - Anaplastic Lymphoma Kinase inhibition as an effective treatment strategy against the enhanced lung carcinogenesis and cancer angiogenesis related to decreased PTPRZ1 expression
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020




CREB signaling in KRAS-driven lung adenocarcinoma
Source: ERS Lung Science Conference 2017
Year: 2017

Targeting STAT3 pathway signalling in EGFR TKI resistant NSCLC
Source: Virtual Congress 2020 – Chronic lung diseases: novel methods, diagnostics and biomarkers
Year: 2020


Enhanced FGFR signaling correlates with erlotinib/bevacizumab response in advanced non-squamous non-small cell lung cancer
Source: International Congress 2015 – Advances in the therapy of lung cancer
Year: 2015


LSC - 2017 - Targeting CD98hc: a key mediator of tumour and microenvironmental crosstalk in malignant mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Met amplification induces an aggressive phenotype in EGFR tyrosine kinase inhibitors resistant non-small-cell lung cancer
Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours
Year: 2015

EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020

WNT5A antagonizes canonical WNT/beta-catenin signaling in lung epithelial cells
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

Salinomycin suppresses TGF-ß1-induced EMT by down-regulating MMP-2,9 via AMPK-SIRT1 pathway in a non-small cell lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

Neurotrophin TrkB receptor mediates the epithelial to mesenchymal transition in lung adenocarcinoma cells
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013

Unexpected hair growth induced by gefitinib treatment in two patients with EGFR gene mutation-positive adenocarcinoma of the lung
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Exosomes form EGFR-mutated adenocarcinoma induce tumour invasion
Source: International Congress 2019 – Biology of lung cancer
Year: 2019


Simvastatin overcomes gefitinib resistance in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor via Akt/b-catenin signaling dependent down-regulation of survivin
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013

Late Breaking Abstract - Activation of Notch1 signalling promotes Bone Marrow-derived Mesenchymal Stem Cells proliferation, migration and survival in COPD microenvironment via PI3K/Akt
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017

MEK5 promotes lung adenocarcinoma
Source: Eur Respir J, 53 (2) 1801327; 10.1183/13993003.01327-2018
Year: 2019



Epidermal growth factor receptor (EGFR) expression in non-small cell lung carcinoma (NSCLC) and survival
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015

NTHi-promoted proliferation of K-ras-induced early lung cancer lesions is fully dependent on Toll-like receptor signaling
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

AXL receptor tyrosine kinase controls epithelial differentiation of human lung progenitor cells
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013